RECITALSTerm Loan and Security Agreement • February 2nd, 2001 • Pharmaceutical Formulations Inc • Pharmaceutical preparations • New York
The CIT Group/ Credit Finance 1211 Avenue of the Americas New York, NY 10036 Tel 212 790-9100 Fax 212 790-9123 THE CIT GROUP October 20, 1999 Pharmaceutical Formulations, Inc. 460 Plainfield Ave. Edison, New Jersey 08817 Re: Loan and Security...Pharmaceutical Formulations Inc • February 2nd, 2001 • Pharmaceutical preparations
CIT Business Credit T: 212-536-1200 1211 Avenue of the Americas New York, NY 10036Pharmaceutical Formulations Inc • February 2nd, 2001 • Pharmaceutical preparations
CIT Business Credit T: 212-536-120 1211 Avenue of the Americas New York, NY 10036Pharmaceutical Formulations Inc • February 2nd, 2001 • Pharmaceutical preparations
Reference is made to the (i) Loan and Security Agreement between you and us, as successor by merger to The CIT Group/Credit Finance, Inc., dated August 4, 1989, as supplemented and amended (the "Loan Agreement") and (ii) the letter agreement between us dated April 26, 1999 with respect to a certain Overadvance (the "Overadvance Letter"). Capitalized terms used and not otherwise defined herein shall have the same meanings given them in the Loan Agreement and/or the Overadvance Letter.
The CIT Group/ Credit Finance 1211 Avenue of the Americas New York, NY 10036 Tel 212 790-9100 Fax 212 790-9123Pharmaceutical Formulations Inc • February 2nd, 2001 • Pharmaceutical preparations
The CIT Group/ Credit Finance 1211 Avenue of the Americas New York, NY 10036 Tel 212 790-9100 Fax 212 790-9123Pharmaceutical Formulations Inc • February 2nd, 2001 • Pharmaceutical preparations
Reference is made to the (i) Loan and Security Agreement between you and us, as successor by merger to The CIT Group/Credit Finance, Inc., dated August 4, 1989, as supplemented and amended (the "Loan Agreement") and (ii) the letter agreement between us dated April 26, 1999 with respect to a certain Overadvance (the "Overadvance Letter"). Capitalized terms used and not otherwise defined herein shall have the same meanings given them in the Loan Agreement and/or the Overadvance Letter.
